The FDA has approved aliskiren, the first of a new class of antihypertensive drugs, the oral renin inhibitors.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content